XNCR Xencor Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik xencor.com (XNCR)

Xencor, Inc. (XNCR) generates stable royalties by licensing unique proteins to pharmaceutical behemoths. The company's technological base serves as the intellectual core for creating effective oncology drugs, while its scaling strategy relies on the expansion of clinical trials. The EV/Sales trajectory illustrates the business value-to-revenue dynamics, where 11508.01 determines the latest valuation metric for the asset's market potential.

Nilai perusahaan marang pendapatan: Xencor Inc (XNCR) kanggo 23.11.2025 - 20.11.2026

xencor.com - rincian analitis lan metrik utama (XNCR)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Xencor, Inc. XNCR
Sampel barang Xencor, Inc.

The EV/Sales ratio determines the value of a business, including net debt, relative to its sales volume. By analyzing changes in the EV/Sales ratio, an investor can gauge the extent of asset overvaluation by the market. The current value of 11508.01 reflects the balance between capitalization and actual revenues. For Xencor, Inc. (XNCR), this metric is stabilizing due to steady royalties from platform licensing. Such financial inertia confirms the fundamental reliability of the business model.

Analisis pesaing Xencor, Inc.

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan CMPX|replimune.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Lyell Pharma|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP